Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading & Placing Update

3 Aug 2012 07:00

RNS Number : 1990J
CAP-XX Limited
03 August 2012
 



CAP-XX Limited

(the "Company" or "CAP-XX")

 

Trading & Placing Update

 

CAP-XX Limited, a world leader in the design and manufacture of revolutionary thin-form supercapacitors, announces that revenues for the year to 30 June 2012 are expected to be AUD $3.5m. Volume and average selling prices are up approximately 15% and 1% respectively compared with the previous year. The loss before tax for the year is expected to be broadly in line with the prior year.

The Company continues to make good progress in direct sales of its supercapacitor products, which considerably extend the performance of conventional battery power systems and, in many new applications, completely eliminates the need for batteries. During the period under review, our licensee, Murata, announced a new "DMG" series of products targeting applications such as Solid State Drives and Automated/Smart Meters for which longer operational life at higher temperatures are required. Royalty payments from Murata have built more slowly than forecast, but their continued investment in product line extensions and increased manufacturing capacity targeted to mobile phone and camera market opportunities supports the Boards' expectations of sales growth over the coming years.

Good progress continues to be made in the development of large cell supercapacitors for automotive applications. Product specifications and requirements have been discussed with the major automotive OEMs and their Tier 1 suppliers, prototype samples provided to several for testing, and the design of a small scale production line completed.

Shipments recently commenced for an exciting new portable medical device to be launched by one of the world's leading diabetes management companies. Additionally new battery-free applications powered by ambient energy harvesters or quick charging systems continue to emerge and are predicted to grow substantially in the coming years.

Although general trading conditions remain flat, the Board continues to view the future with confidence, as the Company's technology is embraced by a widening variety of customers and markets. 

Placing Update

As part of the recent placing of 10,945,333 new ordinary shares announced on March 12, a Chinese automotive component company agreed to subscribe for 1,700,000 of these new ordinary shares in the company, subject to Chinese Government approval.

The Company previously announced that the process of finalising this investment had been delayed. Although the Company continues to pursue this subscription and discussions are ongoing to complete the investment, the Board considers that there is no certainty that the subscription will be completed.

As at June 30, 2012, the Company has AUD $3.8m of cash reserves.

 

For further information, please contact

 

CAP-XX Limited

Anthony Kongats, Chief Executive Officer

 

+61 (0) 2 9428 0139

Seymour Pierce Ltd

Freddy Crossley/Catherine Leftley (Nominated Adviser)

David Banks/Paul Jewell (Corporate Broking)

 

+44 (0) 20 7107 8000

 

Kreab Gavin Anderson & Company (Financial PR)

Robert Speed, Deborah Walter, Anthony Hughes

+44 (0) 20 7074 1800

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUCURUPPGCP
Date   Source Headline
2nd Feb 20267:00 amRNSInterim Results
23rd Jan 20267:00 amRNSNotice of Interim Results & Investor Presentation
19th Dec 202510:13 amRNSReceipt of R&D tax credit
19th Dec 202510:13 amRNSReceipt of R&D tax credit
10th Dec 20252:16 pmRNSHolding(s) in Company
28th Nov 20255:00 pmRNSTotal Voting Rights
28th Nov 202510:13 amRNSResult of AGM
14th Nov 20257:00 amRNSIssue of Shares and Director/PDMR Shareholding
10th Nov 20257:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSFinal results and notice of AGM
30th Oct 20251:02 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSImplementation of Warehouse Management System
10th Sep 202511:48 amRNSHolding(s) in Company
7th Aug 20257:00 amRNSHolding(s) in Company
5th Aug 20257:00 amRNS-RDesign Win with Global Semiconductor Manufacturer
31st Jul 20255:00 pmRNSTotal Voting Rights
25th Jul 20257:00 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSUpdate re. collaboration with SCHURTER
2nd Jul 20257:00 amRNSHolding(s) in Company
1st Jul 20257:29 amRNSIssue of Shares and Director/PDMR Shareholdings
30th Jun 20257:00 amRNSGlobal Distribution Agreement with RS Group plc
9th Jun 20257:00 amRNSBusiness Update and Appointment of Interim CFO
30th May 202510:32 amRNS-RUpdated website
13th May 202511:31 amRNS-RDesign Win with Multinational Conglomerate
30th Apr 20251:57 pmRNSChange of Auditor
26th Mar 20257:00 amRNSGrant of share options
19th Mar 20257:00 amRNSChange of Board Structure and Grant of Options
18th Mar 20259:35 amRNSGlobal Distribution Agreement with Premier Farnell
12th Mar 20252:43 pmRNSTechnology Cooperation Agreement with SCHURTER
7th Mar 20257:00 amRNSMaster Distribution Agreement with Waldom
17th Feb 20257:00 amRNSHalf-year Results
11th Feb 20257:00 amRNSNotice of Interim Results & Investor Presentation
31st Jan 20255:00 pmRNSTotal Voting Rights
21st Jan 20254:27 pmRNSIssue of Shares and Director/PDMR Shareholding
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
17th Jan 20257:00 amRNS-RDistribution agreement with JM Elektronik
15th Jan 20257:00 amRNSFirst shipment to SCHURTER AG
13th Jan 202511:29 amRNSResult of AGM
7th Jan 20257:00 amRNSManagement and board changes
31st Dec 20241:00 pmRNSTotal Voting Rights
9th Dec 202410:19 amRNSNotice of AGM
5th Dec 20248:18 amRNSResult of General Meeting
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20249:57 amRNSDirectors' Subscription
29th Nov 20247:00 amRNSAudited results for the year ended 30 June 2024
5th Nov 20247:00 amRNSResult of Retail Offer, Notice of GM and TVR
1st Nov 20247:00 amRNSResult of Placing
31st Oct 20244:40 pmRNSRetailBook Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.